Keyphrases
Opioid Misuse
100%
Syringe Exchange
100%
Buprenorphine Treatment
100%
HIV Risk
100%
Syringe Services Programs
50%
Opioid Users
30%
HIV Risk Behaviors
20%
Opioid Use Disorder
20%
Out-of-home Care
20%
Buprenorphine Diversion
20%
Cost-effectiveness
20%
Engagement in Treatment
20%
Community Health Centers
20%
Illicit Opioid Use
10%
Barriers to Care
10%
Large Urban Areas
10%
Syrinx
10%
Health Care Delivery
10%
Structural Interventions
10%
Diverse Settings
10%
Randomized Controlled Trial
10%
Formative Research
10%
Health Care Services
10%
Transportation Demand
10%
Opioid Regulations
10%
Structural Barriers
10%
Blister Pack
10%
Control Condition
10%
Opioid Use Disorder Treatment
10%
Specific Intent
10%
Utilization Costs
10%
Buprenorphine
10%
United States
10%
Waiting List
10%
Treatment Engagement
10%
Opioid Overdose
10%
Health Service Utilization
10%
Behavioral Model for Vulnerable Populations
10%
Overdose Deaths
10%
People Who Inject Drugs
10%
Program Participant
10%
Service Utilization
10%
Nursing and Health Professions
Human Immunodeficiency Virus
100%
Buprenorphine
100%
Syringe
100%
Maintenance Therapy
61%
Patient Referral
23%
Health Center
15%
Cost Effectiveness Analysis
15%
Risk Behavior
15%
Diseases
15%
Randomization
7%
Health Care Utilization
7%
Blister Pack
7%
Vulnerable Population
7%
Health Care Delivery
7%
Combination Therapy
7%
Health Care
7%
Medicine and Dentistry
Buprenorphine
100%
Human Immunodeficiency Virus Risk Behavior
100%
Maintenance Therapy
61%
Patient Referral
23%
Community Health
15%
Health Care Cost
15%
Cost-Effectiveness Analysis
15%
Health Service
15%
High Risk Behavior
15%
Human Immunodeficiency Virus
7%
Vulnerable Population
7%
Blister
7%
Combination Therapy
7%
Arm
7%
Randomized Controlled Trial
7%
Delivery of Health Care
7%
Primary Outcome
7%